Literature DB >> 474620

Mutations affecting pigmentation in man: I. Neuroectodermal melanolysosomal disease.

B R Elejalde, J Holguin, A Valencia, E F Gilbert, J Molina, G Marin, L A Arango.   

Abstract

We describe a syndrome identified in three consanguineous families who had two and probably four common ancestors five generations ago. The syndrome is characterized by profound dysfunction of the central nervous system, silver-leaden colored hair, abnormal melanosomes and melanocytes, and abnormal inclusion bodies in fibroblasts, bone marrow histiocytes and lymphocytes which appear to represent abnormal lysosomal bodies. Because of the biochemical relationships between melanin-melanosomes and neuromelanin, we think that all the manifestations of the condition are related to and represent pleiotropic effects of a newly identified gene in man in its homozygous state. Biochemical reactions of the cells of these patients indicate presence of tyrosinase in the melanosomes.and show that the substance accumulated in cultured fibroblasts and in the bone marrow histiocytes is a PAS and Oil-red-O positive material but is Oil-red-O negative after extraction; it has the typical reactions of melanin withe the Masson and Fontana stain, but cannot be considered typical melanin, since without stain it is colorless. The ultrastructural studies showed round granules with variable matrix, similar in fibroblast and bone marrow, and with variable intensity of reaction to osmium. This mutation principally affects the neuroectoderm, but also the mesoderm.

Entities:  

Mesh:

Year:  1979        PMID: 474620     DOI: 10.1002/ajmg.1320030112

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  An oculocerebral hypopigmentation syndrome: a case report with clinical, histochemical, and ultrastructural findings.

Authors:  M A Patton; M Baraitser; A H Heagerty; R A Eady
Journal:  J Med Genet       Date:  1987-02       Impact factor: 6.318

2.  Bone marrow transplantation (BMT) for the syndrome of pigmentary dilution and lymphohistiocytosis (Griscelli's syndrome).

Authors:  L C Schneider; R S Berman; C R Shea; A R Perez-Atayde; H Weinstein; R S Geha
Journal:  J Clin Immunol       Date:  1990-05       Impact factor: 8.317

3.  Griscelli disease: genotype-phenotype correlation in an array of clinical heterogeneity.

Authors:  Ozden Sanal; Fúgen Ersoy; Ilhan Tezcan; Ayşe Metin; Leman Yel; Gaël Ménasché; Aytemiz Gürgey; Izzet Berkel; Geneviève de Saint Basile
Journal:  J Clin Immunol       Date:  2002-07       Impact factor: 8.317

4.  A kindred with Griscelli disease: spectrum of neurological involvement.

Authors:  H Hurvitz; R Gillis; S Klaus; A Klar; F Gross-Kieselstein; E Okon
Journal:  Eur J Pediatr       Date:  1993-05       Impact factor: 3.183

5.  Evidence that Griscelli syndrome with neurological involvement is caused by mutations in RAB27A, not MYO5A.

Authors:  Yair Anikster; Marjan Huizing; Paul D Anderson; Diana L Fitzpatrick; Aharon Klar; Eva Gross-Kieselstein; Yackov Berkun; Gila Shazberg; William A Gahl; Haggit Hurvitz
Journal:  Am J Hum Genet       Date:  2002-06-07       Impact factor: 11.025

6.  Myosin Va interacts with the exosomal protein spermine synthase.

Authors:  Luciano G Dolce; Rui M P Silva-Junior; Leandro H P Assis; Andrey F Z Nascimento; Jackeline S Araujo; Ingrid P Meschede; Enilza M Espreafico; Priscila O de Giuseppe; Mário T Murakami
Journal:  Biosci Rep       Date:  2019-03-01       Impact factor: 3.840

7.  Myosin Va Brain-Specific Mutation Alters Mouse Behavior and Disrupts Hippocampal Synapses.

Authors:  Swarna Pandian; Jian-Ping Zhao; Yasunobu Murata; Fernando J Bustos; Cansu Tunca; Ramiro D Almeida; Martha Constantine-Paton
Journal:  eNeuro       Date:  2020-11-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.